Assignee
FOREST LAB HOLDINGS LTD
BM·20 granted patents·51 pending applications·144 citations·filing 2004–2015
Top patents by PatentIndex Score
71 records- 0194US9062053B2Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-Diazabicyclo[3,2,1]octane-2-carboxamide sodium saltFOREST LAB HOLDINGS LTD·Filed 2014·Granted Jun 23, 2015·15 cites·9 claims
- 0294US8835455B2Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium saltFOREST LAB HOLDINGS LTD·Filed 2013·Granted Sep 16, 2014·15 cites·10 claims
- 0392US8039009B2Modified release formulations of memantine oral dosage formsFOREST LAB HOLDINGS LTD·Filed 2005·Granted Oct 18, 2011·61 cites·23 claims
- 0488US7829569B2Solvate and crystalline forms of carbamoyl-cyclohexane derivativesFOREST LAB HOLDINGS LTD·Filed 2008·Granted Nov 9, 2010·15 cites·9 claims
- 0584US7456224B2Method for treating autismFOREST LAB HOLDINGS LTD·Filed 2004·Granted Nov 25, 2008·18 cites·4 claims
- 0681US8815870B24-(2-(6-substituted-hexylidene) hydrazinyl)benzonitrile and preparation thereofFOREST LAB HOLDINGS LTD·Filed 2013·Granted Aug 26, 2014·2 cites·13 claims
- 0781US7838552B2Compositions comprising nebivololFOREST LAB HOLDINGS LTD·Filed 2005·Granted Nov 23, 2010·3 cites·12 claims
- 0877US7803838B2Compositions comprising nebivololFOREST LAB HOLDINGS LTD·Filed 2005·Granted Sep 28, 2010·1 cites·12 claims
- 0975US9283261B2Linaclotide compositionsFOREST LAB HOLDINGS LTD·Filed 2014·Granted Mar 15, 2016·1 cites·22 claims
- 1075US9221821B2Methods for the synthesis of 1,3-substituted aminouracils and other xanthine-related compoundsFOREST LAB HOLDINGS LTD·Filed 2013·Granted Dec 29, 2015·2 cites·35 claims
- 1172US7842696B2Piperazine derivatives as inhibitors of stearoyl-CoA desaturaseFOREST LAB HOLDINGS LTD·Filed 2008·Granted Nov 30, 2010·3 cites·53 claims
- 1272US7501438B2Pyridoimidazole derivativesFOREST LAB HOLDINGS LTD·Filed 2007·Granted Mar 10, 2009·1 cites·24 claims
- 1371US8044041B2Phthalazine derivatives as inhibitors of protein kinaseFOREST LAB HOLDINGS LTD·Filed 2007·Granted Oct 25, 2011·1 cites·32 claims
- 1471US7897595B2Pyridoazepine derivativesFOREST LAB HOLDINGS LTD·Filed 2007·Granted Mar 1, 2011·1 cites·29 claims
- 1569US8633241B2Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivololFOREST LAB HOLDINGS LTD·Filed 2013·Granted Jan 21, 2014·2 cites·32 claims
- 1669US7569605B2Methods of treating central nervous system disorders with a low dose combination of escitalopram and bupropionFOREST LAB HOLDINGS LTD·Filed 2006·Granted Aug 4, 2009·2 cites·9 claims
- 1769US2009247644A1Memantine formulationsFOREST LAB HOLDINGS LTD·Filed 2009·Application pending·0 cites
- 1868US9259403B2Crystalline forms of (1S,2R)-2-(amino methyl)-N,N-diethyl-1-phenyl cyclopropane carboxamideFOREST LAB HOLDINGS LTD·Filed 2014·Granted Feb 16, 2016·0 cites·6 claims
- 1968US8039463B2Piperazine derivatives as inhibitors of stearoyl-CoA desaturaseFOREST LAB HOLDINGS LTD·Filed 2009·Granted Oct 18, 2011·1 cites·10 claims
- 2068US2010081723A1Memantine For The Treatment Of Childhood Behavioral DisordersFOREST LAB HOLDINGS LTD·Filed 2009·Application pending·0 cites
- 2168US2009275597A1Methods of treating cns disordersFOREST LAB HOLDINGS LTD·Filed 2009·Application pending·0 cites
- 2266US2009048348A1Method for treating autismFOREST LAB HOLDINGS LTD·Filed 2008·Application pending·0 cites
- 2365US2013302430A1Modified and immediate release formulations of memantineFOREST LAB HOLDINGS LTD·Filed 2013·Application pending·0 cites
- 2465US2009143593A1Synthesis of heterocyclic compoundsFOREST LAB HOLDINGS LTD·Filed 2009·Application pending·0 cites
- 2563US7511150B2Synthesis of heterocyclic compoundsFOREST LAB HOLDINGS LTD·Filed 2007·Granted Mar 31, 2009·0 cites·18 claims
- 2662US2014018307A1Linaclotide compositionsFOREST LAB HOLDINGS LTD·Filed 2013·Application pending·0 cites
- 2762US2013210919A1Novel crystalline forms of (1s,2r)-2-(amino methyl)-n,n-diethyl-1-phenyl cyclopropane carboxamideFOREST LAB HOLDINGS LTD·Filed 2013·Application pending·0 cites
- 2861US2014213659A1Modified release formulations of memantine oral dosage formsFOREST LAB HOLDINGS LTD·Filed 2014·Application pending·0 cites
- 2961US2013253063A1Stable dosage forms of levomilnacipranFOREST LAB HOLDINGS LTD·Filed 2013·Application pending·0 cites
- 3061US2009082326A1Soluble dosage forms containing cephem derivatives suitable for parenteral administrationFOREST LAB HOLDINGS LTD·Filed 2008·Application pending·0 cites
- 3161US2013273169A1Stable Solid Formulation of GC-C Receptor Agonist Polypeptide Suitable for Oral AdministrationFOREST LAB HOLDINGS LTD·Filed 2013·Application pending·0 cites
- 3261US2015065582A1Orally Dissolving Formulations of MemantineFOREST LAB HOLDINGS LTD·Filed 2014·Application pending·0 cites
- 3360US2009036468A1Pharmaceutical compositions containing dopamine receptor ligands and methods of treatment using dopamine receptor ligandsFOREST LAB HOLDINGS LTD·Filed 2008·Application pending·0 cites
- 3460US2009192315A1Synthesis of heterocyclic compoundsFOREST LAB HOLDINGS LTD·Filed 2008·Application pending·0 cites
- 3560US2013310460A1Modified release formulations of memantine oral dosage formsFOREST LAB HOLDINGS LTD·Filed 2013·Application pending·0 cites
- 3660US2008008743A1Orally Dissolving Formulations of MemantineFOREST LAB HOLDINGS LTD·Filed 2007·Application pending·0 cites
- 3760US2015258042A1Modified and immediate release formulations of memantineFOREST LAB HOLDINGS LTD·Filed 2015·Application pending·0 cites
- 3859US2014348932A1Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexaneFOREST LAB HOLDINGS LTD·Filed 2014·Application pending·0 cites
- 3958US2013012593A1Modified release formulations of memantine oral dosage formsFOREST LAB HOLDINGS LTD·Filed 2012·Application pending·0 cites
- 4057US2014057954A1Chemical compositionFOREST LAB HOLDINGS LTD·Filed 2013·Application pending·0 cites
- 4157US2013011474A1Modified and immediate release formulations of memantineFOREST LAB HOLDINGS LTD·Filed 2012·Application pending·0 cites
- 4255US2011245254A1Heterocyclic compounds as inhibitors of beta-lactamasesFOREST LAB HOLDINGS LTD·Filed 2011·Application pending·0 cites
- 4355US2015148424A1Stable dosage forms of levomilnacipranFOREST LAB HOLDINGS LTD·Filed 2015·Application pending·0 cites
- 4455US2015157575A1Pharmaceutical Formulations Comprising VilazodoneFOREST LAB HOLDINGS LTD·Filed 2014·Application pending·0 cites
- 4554US2015031632A1Orally Disintegrating Compositions of LinaclotideFOREST LAB HOLDINGS LTD·Filed 2014·Application pending·0 cites
- 4654US2015258031A1Modified release formulations of memantine oral dosage formsFOREST LAB HOLDINGS LTD·Filed 2015·Application pending·0 cites
- 4754US2015132382A1Compositions and methods of treatment comprising fosfomycin disodiumFOREST LAB HOLDINGS LTD·Filed 2014·Application pending·0 cites
- 4853US2010048726A1Memantine For The Treatment Of Mild And Mild To Moderate Alzheimer's DiseaseFOREST LAB HOLDINGS LTD·Filed 2009·Application pending·0 cites
- 4953US2015148427A1Modified release formulations of memantine oral dosage formsFOREST LAB HOLDINGS LTD·Filed 2015·Application pending·0 cites
- 5053US2013012712A1Method for preparing disubstituted piperidine and intermediatesFOREST LAB HOLDINGS LTD·Filed 2012·Application pending·0 cites
Showing the top 50 of 71 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when FOREST LAB HOLDINGS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →